1. Bollerslev J, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015 Aug;173(2):G1-20.
  2. Brandi ML, et al. Management of Hypoparathyroidism: Summary Statement and Guidelines. The Journal of Clinical Endocrinology & Metabolism. 2016 Jun 1;101(6):2273–83.
  3. Chen K, et al. Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review. Journal of Medical Economics. 2019 Jun 17;22(11):1141–52.
  4. Mannstadt M, et al. Hypoparathyroidism. Nat Rev Dis Primers. 2017 Aug 31;3:17055.
  5. Clarke BL, et al. Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metab. 2016 Jun 1;101(6):2284–2299.
  6. Khan AA, et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019 Mar 01;180(3):1-22.
  7. Ascendis Pharma UK. Data on file. 2025.
  8. Shoback DM, et al. J Clin Endocrinol Metab. 2016;101(6):2300–12.
  9. National Cancer Institute. Bone Density. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-density. [accessed October 2025].
  10. Medline Plus. Calcification. Available from: https://medlineplus.gov/ency/article/002321.htm [accessed October 2025].
  11. National Cancer Institute. Cognitive impairment. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cognitive-impairment. [accessed October 2025].
  12. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011.
  13. Qadeer HA, Bashire K. Physiology, Phosphate. StatPearls. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560925/. [accessed October 2025].
  14. Goyal A, et al. Hypocalcemia. StatPearls. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430912/. [accessed October 2025].
  15. Goyal R, Jialal I. Hyperphosphatemia. StatPearls. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551586/. [accessed October 2025].
  16. National Cancer Institute. Renal Failure. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/renal-failure. [accessed October 2025].
  17. Brod M, et al. Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact). Qual Life Res. 2021 Jan;30(1):277-291. doi: 10.1007/s11136-020-02607-1. Epub 2020 Aug 24. PMID: 32833143; PMCID: PMC7847873.
  18. Kontogeorgos G, et al. Low health-related quality of life in hypoparathyroidism and need for PTH analog. Endocrine Connections. 2022 Jan 10;11(1).
  19. Ascendis Pharma UK. Data on file. 2024.

Expert Views on Hypopara

Woman with coffee looking out of window

Expert Views on Hypopara

The Seeds of Change initiative is committed to supporting greater understanding of hypoparathyroidism (hypopara) and the impact it has on patients’ lives. Through collaboration with leading professionals in hypopara, we explore the complexities of hypopara management, share insights from real patient experiences, and reflect on how clinical practice can continue to evolve – helping healthcare professionals better support those living with this rare condition.

Articles

Improving multidisciplinary care in hypoparathyroidism: a conversation across specialties


Given people living with hypoparathyroidism will likely interact with several specialists as part of their management, how can healthcare professionals ensure care remains coordinated, consistent and centred around the individual? In this expert discussion, Professor Jeremy Turner and Mr Shad Khan explore the realities of managing a complex rare condition across multiple disciplines, how stronger collaboration can help improve patient outcomes, and practical ways to implement closer working.

Download
By Professor Jeremy Turner, Consultant Endocrinologist, and Mr Shad Khan, Consultant Endocrine Surgeon

By Professor Jeremy Turner, Consultant Endocrinologist, and Mr Shad Khan, Consultant Endocrine Surgeon

What patients can teach us about the long-term management of hypoparathyroidism


Through a conversation with Lydia Hale, a woman living with hypoparathyroidism, Consultant Endocrinologist Dr Lavanya Pelluri explores how people living with this rare condition often develop a deep understanding of their health over time, recognising symptom patterns and early warning signs that may not always be captured during routine monitoring. The article examines how combining clinical expertise with lived experience can help create a more complete picture of disease burden, support shared decision-making, and ensure long-term management is centred around what matters most to each individual patient.

Download
Dr Lavanya Pelluri, Consultant Endocrinologist at University Hospital Birmingham, in conversation with Lydia Hale, a woman living with chronic hypoparathyroidism

By Dr Lavanya Pelluri, Consultant Endocrinologist at University Hospital Birmingham, in conversation with Lydia Hale, a woman living with chronic hypoparathyroidism

Beyond the Numbers: Breaking Down Misconceptions in Hypoparathyroidism


Dr Hassan-Smith reflects on the potential limitations of a metrics-only approach to hypopara management, the need to recognise psychological burden, long-term complications, and the role of patient empowerment and community support in improving outcomes.

Download
Dr Zaki Hassan Smith

By Dr Zaki Hassan-Smith, Honorary Consultant Endocrinologist, University Hospitals Birmingham NHS Foundation Trust; Clinical Associate Professor, Aston University.

The Silent Condition: Managing Long-Term Complications in Hypoparathyroidism


Dr Abbas focuses on the often-overlooked long-term complications of hypopara, including renal, cardiovascular, bone and cognitive risk.

He highlights the importance of proactive monitoring, multidisciplinary care and patient education to achieve improved long-term outcomes for people living with hypopara.

Download
Dr Afroze Abbas

By Dr Afroze Abbas, Consultant Endocrinologist, Leeds Teaching Hospitals NHS Trust.

Missing from the Metrics: Navigating Symptom Fluctuations in Hypopara Care for Women


Dr Victoria Stokes discusses the challenges faced by women living with hypoparathyroidism, particularly during pregnancy, postpartum, and perimenopause, where hormonal fluctuations and life stages complicate symptom management and monitoring. She highlights the potential limitations of current care models that rely on infrequent biochemical assessments, advocating for more dynamic, patient-centred approaches.

Download
Victoria Stokes

By Dr Victoria Stokes, Consultant Endocrinologist at Cambridge University Hospitals NHS Foundation Trust.

Think Calcium, Think Long-Term: Bridging the Gaps in the Hypoparathyroidism Care Pathway


Professor Selby provides advice on identifying and addressing gaps in the hypopara patient pathway, and the importance of primary and secondary care professionals remaining vigilant to calcium monitoring and the risk of long-term consequences.

Download
Professor Peter Selby

By Professor Peter Selby, Consultant Physician and Honorary Clinical Professor of Metabolic Bone Disease.

When ‘In Range’ Isn’t Enough: The Importance of Quality of Life in Hypoparathyroidism


Helen Loo explores why biochemical stability alone does not fully reflect the lived experience of people with hypoparathyroidism. Despite being “in range”, many patients continue to face significant physical, cognitive and emotional symptoms that often go unrecognised.

Loo discusses how formal quality‑of‑life tools can support more meaningful, consistent assessment, enabling clinicians to identify unmet needs, validate patient experiences, and track progress over time.

Download
Helen Loo

By Helen Loo, Endocrine Specialist Nurse at Oxford University Hospitals.

“For some people with hypopara, their symptoms can be well managed. For others however, managing the condition can be very challenging, mainly due to its broad and indistinct symptoms”

Dr Zaki Hassan-Smith

“Clinicians must remain vigilant about the potential long-term complications of hypopara that can emerge over time”

Dr Zaki Hassan-Smith

“Evolving management practices that include comprehensive long-term care strategies are required to ensure physicians can keep patients out of hospital, whilst minimising the complications related to chronic hypopara”

Dr Zaki Hassan-Smith

“In today’s hypopara treatment landscape, the current focus on short-term serum calcium correction is not going far enough. Effective management demands a broader and more comprehensive approach”

Dr Afroze Abbas

“Looking ahead, we must reframe the way we think about hypopara. This includes investment in and implementing more regular proactive surveillance of long-term complications”

Dr Afroze Abbas

“We must continue focusing on patient education and empowerment, to help individuals living with hypopara and their families to better understand their condition and manage symptoms”

Dr Afroze Abbas

“To ensure continuity of care, it is critical that all healthcare professionals involved in maternity care, including obstetricians, midwives and general practitioners, are aware of the continuous monitoring requirements for women with hypopara”

Dr Victoria Stokes

“Differentiating between perimenopausal changes and hypopara-related symptom manifestations can be challenging for both patients and clinicians. This often necessitates a more nuanced and collaborative approach to management”

Dr Victoria Stokes

“Optimising the hypopara pathway requires a multi-pronged approach across primary care professionals (from GPs to pharmacists), endocrinologists (specialist bone and calcium experts and more general endocrine doctors and nurses), and patients and carers themselves”

Professor Peter Selby

“We need to improve the systematic review of long-term medication use to ensure that proactive monitoring is embedded and therefore over-treatment is flagged early. Other chronic conditions, like diabetes, offer a useful comparison”

Professor Peter Selby

“When symptoms persist despite patients being told their biochemical results are stable, they may feel the impact of their hypoparathyroidism is being underestimated or “brushed over””

Helen Loo

“If we want to plant the seeds for long-term change, we need to start measuring the whole impact of hypoparathyroidism – and begin by making space for the question that patients often wish we asked first: “how have you been since we last spoke?””

Helen Loo